4,6-diarylpyrimidine derivatives (Otsuka)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Name4,6-diarylpyrimidine derivatives (Otsuka)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsPsoriasisRetinal DiseasesArthritis +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOtsuka Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPsoriasisRetinal DiseasesArthritis +[4

Other Information

ATC CodeN/A
Related LinksN/A